Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial
The findings of this study demonstrated noninferiority along with comparable PK, safety, and immunogenicity of biosimilar cetuximab and IC in patients with recurrent or metastatic SCCHN.
Authors
- Dhruv Mehta (ORCID: https://orcid.org/0000-0001-8314-9385)
- Nilesh Dhamne
- K Shilpa
- Vanita Noronha (ORCID: https://orcid.org/0000-0002-0191-2744)
- Chetan Deshmukh (ORCID: https://orcid.org/0000-0003-2881-4228)
- Nandini Menon
- Hemant Malhotra (ORCID: https://orcid.org/0000-0001-5613-5375)
- Koushik Chatterjee
- Bellala Ravishankar
- Saroj Majumdar (ORCID: https://orcid.org/0000-0001-7151-6539)
- Amol Aiwale (ORCID: https://orcid.org/0000-0002-5118-1871)
- Chandan Krushna Das (ORCID: https://orcid.org/0000-0003-2159-8227)
- Akhilesh Sharma (ORCID: https://orcid.org/0000-0002-4482-3709)
- Prasanth Ganesan (ORCID: https://orcid.org/0000-0003-2762-6591)
- Vinayaka Shahavi
- Vijay Mahobia
- Rajiv Yadav (ORCID: https://orcid.org/0000-0002-1707-7325)
- Rohitashwa Dana
- M. Avaronnan
- Vashishth Maniar
- Kumar Prabhash (ORCID: https://orcid.org/0000-0001-8858-5004)
- Vaibhav Chaudhary (ORCID: https://orcid.org/0009-0003-5161-650X)
- Atul Sharma
- Minish Jain (ORCID: https://orcid.org/0000-0002-4394-3055)
- Rejnish Kumar
- Roshan Pawar
- Suhas Aagre (ORCID: https://orcid.org/0000-0002-1407-9130)
- P. Shivanna
- P. Chaithanya
- Kartar Singh
- Rajnish Nagarakar
Institutions
- Malabar Cancer Centre (IN)
- Gandhi Medical College & Hospital (IN)
- SMS Medical College (IN)
- Government Medical College (IN)
- Tata Memorial Hospital (IN)
- Regional Cancer Center, Thiruvananthapuram (IN)
- MNJ Institute Of Oncology and Regional Cancer Centre (IN)
- Nirma (India) (IN)
- Deenanath Mangeshkar Hospital and Research Center (IN)
- All India Institute of Medical Sciences Bhubaneswar (IN)
- Cancer Hospital and Research Institute (IN)
- Mysore Medical College (IN)
- Shri Vile Parle Kelavani Mandal (IN)
- HCG Cancer Centre (IN)
- Alkem (India) (IN)
- King George Hospital (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- Jawaharlal Institute of Post Graduate Medical Education and Research (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1200/go.24.00059
- Citations
- 5
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.41